首页> 外国专利> {6 - 4 - (4-ethyl-pyridine-1-slug-slug-phenyl) - phenyl - 7h pirrolo 2,3-d pirimidin-4-il} ((R) - 1-phenyl-ethyl) - amines in cancer treatment

{6 - 4 - (4-ethyl-pyridine-1-slug-slug-phenyl) - phenyl - 7h pirrolo 2,3-d pirimidin-4-il} ((R) - 1-phenyl-ethyl) - amines in cancer treatment

机译:{6-[4--(4-乙基吡啶-1-sl-苯基-苯基)-苯基]-7h吡咯罗[2,3-d]吡氨基-4-il}((R)-1-苯基乙基)-胺类药物在癌症治疗中的作用

摘要

It refers to a crystal form, namely {6 - [4 - (4 - (4-ethyl-pyridine-1-aldehydes-aldehydes-phenyl) - phenyl-7-pyridine-4 - ((R) - 1-phenyl-ethyl) - ammonia water, characterized by X-ray derivative properties, expressed in terms of 2 theta angulos, including 5 or more 4.4; 8.8; 9.1; 13.2; 14.2; 17.0 +. Within the infrared absorption spectrum of about 695, 802, 836, 923, 1013, 1095, 1146, 1165, 1207, 1229, 1292, 1300, 1310, 1348, 1358, 1507, 1546, 1595 and 3269 + - 2cm-1. The preparatory process was also mentioned. The compounds inhibit the use of EFG and VEGF in breast, colon and ovarian cancer
机译:它是指晶体形式,即{6- [4--(4--(4-乙基-吡啶-1-醛-醛-苯基)-苯基-7-吡啶-4-((R)-1-苯基-乙)-氨水,以X射线导数特性为特征,以2θ安古洛斯表示,包括5个或更多的4.4; 8.8; 9.1; 13.2; 14.2; 17.0 +。在约695、802, 836,923,1013,1095,1146,1165,1207,1229,1292,1300,1310,1348,1358,1507,1546,1595和3269 +-2cm-1。还提到了制备过程。 EFG和VEGF在乳腺癌,结肠癌和卵巢癌中的应用

著录项

  • 公开/公告号PE20071323A1

    专利类型

  • 公开/公告日2008-02-15

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号PE2007000072

  • 发明设计人 MUTZ MICHAEL;FISHER RETO;

    申请日2007-01-23

  • 分类号A61K31/519;A61P35;C07D487/04;

  • 国家 PE

  • 入库时间 2022-08-21 20:06:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号